Royal Bank of Canada
BLTE

Royal Bank of Canada’s Belite Bio BLTE Stock Holding History

Royal Bank of Canada’s Portfolio BLTE Stock Details BLTE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$360K Buy
2,257
+165
+8% +$27.7K ﹤0.01% 4360
2025
Q4 		$334K Buy
+2,092
New +$248K ﹤0.01% 4456
2025
Q1 		– Sell
-5
Closed – – 6824
2024
Q4 		$0 Buy
+5
New +$330 ﹤0.01% 6900
2023
Q2 		– Sell
-94
Closed -$3K – 7259
2023
Q1 		$3K Buy
+94
New +$2.86K ﹤0.01% 6674

Other funds holding BLTE

DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Royal Bank of Canada's BLTE Position: Q1 2026 in Review

Royal Bank of Canada increased its Belite Bio (BLTE) stake by 7.9% in Q1 2026, buying an estimated $27.7K and bringing the position to 2,257 shares worth $360K. The position accounts for ﹤0.01% of the portfolio, ranked #4360.

Royal Bank of Canada first reported a position in BLTE in Q1 2023 and has held it in 4 quarters since. 75 funds tracked by Wall St. Rank hold BLTE as of Q1 2026.

  • Royal Bank of Canada held 2,257 shares of Belite Bio worth $360K as of Q1 2026.
  • Royal Bank of Canada bought 165 Belite Bio shares in Q1 2026, an estimated $27.7K.
  • Belite Bio made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #4360 holding.
  • Royal Bank of Canada first reported a position in Belite Bio in Q1 2023 and has held it in 4 quarters since.
  • 75 funds tracked by Wall St. Rank held Belite Bio as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.